-
Biopharmaceutical |Mafu a pelo |2-Chloro-L-phenylalanine |CAS No.185030-83-5
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Mafu a pelo |Khatello ea Mali e Phahameng |2-CHLORO-L-PHENYLALANINE |CAS: 185030-83-5 |C9H10ClNO2
-
3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 330786-24-8
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Indasteri Pharmaceutical |Lithethefatsi tsa Antitumor |Ibrutinib Intermediates |3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |CAS: 330786-24-8 |C17H13N5O
-
3-Amino-4-cyano-5-(4-phenoxyphenyl)pyrazole 330792-70-6
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Indasteri Pharmaceutical |Lithethefatsi tsa Antitumor |Ibrutinib Intermediates |3-Amino-4-cyano-5-(4-phenoxyphenyl)pyrazole |CAS: 330792-70-6|Setšoantšo sa C16H12N4O
-
1,4-Bis(4-aminophenoxy)benzene 3491-12-1
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Lisebelisoa tsa k'hemistri |Polyimide monomers |1,4-Bis(4-aminophenoxy)benzene |CAS: 3491-12-1 |C18H16N2O2
-
Itopride hydrochloride 122892-31-3
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Indasteri API |Lithethefatsi tsa tsamaiso ea lijo |Itopride hydrochloride le li-Intermediates tsa eona |Itopride hydrochloride |CAS: 122892-31-3 |C20H26N2O4.HCl
-
Benazepril hydrochloride 86541-74-4
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Mafu a pelo |Khatello ea Mali e Phahameng |Benazepril hydrochloride |CAS: 86541-74-4|C24H28N2O5.HCl
-
1-Boc-3-hydroxypiperidine 85275-45-2
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Indasteri Pharmaceutical |Lithethefatsi tsa Antitumor |Ibrutinib Intermediates |1-Boc-3-hydroxypiperidine |CAS: 85275-45-2 |C10H19NO3
-
L-Leucine benzyl ester p-toluenesulfonate letsoai 1738-77-8
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Immunology |Peptide synthesis |L-Leucine benzyl ester p-toluenesulfonate letsoai |CAS: 1738-77-8 |C13H19NO2.C7H8O3S
-
Boc-D-Serine 6368-20-3
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Immunology |Peptide synthesis |Amino acid letoto la Natural Amino Acid |Boc-D-Serine |CAS: 6368-20-3 |C8H15NO5
-
D-Serine 312-84-5
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Immunology |Peptide synthesis |Letoto la amino acid |D-Serine |CAS: 312-84-5 |C3H7NO3
-
Boc-D-3-Bromophenylalanine 261360-77-4
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Immunology |Peptide synthesis |Letoto la amino acid |Boc-D-3-Bromophenylalanine |CAS: 261360-77-4 |C14H18BrNO4
-
Boc-L-aspartic acid 13726-67-5
Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Immunology |Peptide synthesis |Letoto la amino acid |Boc-L-aspartic acid |CAS: 13726-67-5 |C9H15NO6